Matsushita, Hiroki
Saku, Keita http://orcid.org/0000-0002-6856-9362
Nishikawa, Takuya
Yokota, Shohei
Sato, Kei
Morita, Hidetaka
Yoshida, Yuki
Fukumitsu, Masafumi
Uemura, Kazunori
Kawada, Toru
Yamaura, Ken
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K08222)
Japan Agency for Medical Research and Development (23hk0102085h0002, 23uk1024007h0001)
Ministry of Internal Affairs and Communications (JP225006004)
Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center (21-2-7, 21-2-9)
Japan Science and Technology Agency (JPMJPF2018)
Article History
Received: 4 December 2023
Accepted: 18 January 2024
First Online: 16 February 2024
Declarations
:
: This study involved computational simulations and did not include human participants, animals, or field studies. As such, traditional ethics approval and consent were not applicable.
: Not applicable.
: Matsushita H, Nishikawa T, Yokota S, Sato K, Morita H, Yoshida Y, Fukumitsu M, Uemura K, Kawada T, and Yamaura K have nothing to declare. Saku K received research funding from Abiomed, Inc., NTT Research, Inc., Asahi Kasei ZOLL Medical Corporation, Neuroceuticals Inc., and Zeon Medical Inc., and honoraria from Abiomed Japan K.K., Mallinckrodt Pharma K.K., and Ono Pharmaceutical Co., Ltd.